Skip to main content
. 2022 Nov 22;49(2):507–517. doi: 10.1093/schbul/sbac170

Table 3.

Demographic and Clinical Data of the Clusters

Highly Rigid and Slowed Patients Less Rigid and Slowed Patients Comparison FDR-corr. P-value
N 42 29
Age in years 37.3 ± 14.4 34.6 ± 11.0 F(1, 69) = 0.8, P = .388 .466
Gender 21M 15M X 2 (1, N = 71) = 0.02, P = .886 .997
Education in years 13.0 ± 2.4 13.0 ± 2.4 F(1, 69) =.001, P = .977 .977
Duration of illness in years 12.6 ± 11.4 8.0 ± 7.9 F(1, 69) = 3.5, P = .066 .108
Nr. of episodes 6.2 ± 5.4 3.5 ± 2.6 F(1, 69) = 6.2, P = .015 .030*
SRRS total 26.3 ± 6.7 22.0 ± 5.0 F(1, 69) = 8.7, P = .004 .013*
PANSS Total 87.2 ± 21.6 75.7 ± 12.2 F(1, 69) = 6.7, P = .012 .026*
PANSS Positive 17.6 ± 6.6 15.0 ± 4.1 F(1, 69) = 3.5, P = .066 .100
PANSS Negative 26.0 ± 7.2 22.2 ± 4.9 F(1, 69) = 6.2, P =.015 .027*
Medication OLZ eq. in mg 17.7 ± 11.7 15.3 ± 9.7 F(1, 69) = 0.8, P = .374 .481
UPDRS 25.4 ± 12.1 16.9 ± 11.7 F(1, 69) = 8.7, P = .004 .015*
BFCRS 5.9 ± 4.9 5.2 ± 4.3 F(1, 69) = 2.2, P = .146 .203
mSRRS 11.5 ± 3.1 9.6 ± 2.9 F(1, 69) = 6.8, P = .011 .029*
IPAQ 1400.7 ± 2376.3 1382.0 ± 2324.5 F(1, 69) = 0.001, P = .974 >.9
Actigraphy 11313.6 ± 3584.4 15552.5 ± 5076.9 F(1, 69) = 17.0, P < .001 <.001***
Gait velocity 94.6 ± 20.1 113.6 ± 19.9 F(1, 69) = 15.5, P < .001 <.001***
CR dominant hand 8.6 ± 2.4 14.5 ± 1.8 F(1, 69) = 125.9, P < .001 <.001***
CR non-dominant hand 7.9 ± 2.4 12.2 ± 2.1 F(1, 69) = 62.1, P < .001 <.001***

Note: Displayed are mean ± sd of demographic and clinical variables for each cluster within the PS group. Sd, Standard deviation; SRRS, Salpêtrière Retardation Rating Scale; PANSS, Positive And Negative Syndrome Scale; OLZ eq., Olanzapine-equivalent (mg/day); UPDRS, Unified Parkinson Disease Rating Scale Part III; BFCRS, Bush-Francis Catatonia Rating Scale; mSRRS, motor score of SRRS; IPAQ, International Physical Activity Questionnaire; CR, Coin rotation task; M, male.